Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Strategy for Beer in Adolescents with T1D
NCT02518022Withdrawn
- Sponsor
- Kinderkrankenhaus Auf der Bult
- Start
- Sep 2015
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human insulin in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Kinderkrankenhaus Auf der Bult. Primary endpoint: Number of hypoglycaemic events <70 mg/dl per arm from begin of consumption until lunch next day at 18 hours. Planned start Sep 2015; status: withdrawn.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02518022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02518022.